CHINEDU ARUKWE: Open Payments
NPI 1437798238 · RICHMOND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,476 in 68 payments from 13 companies in 2025. Trend: 2023 $1,791 · 2024 $1,100 · 2025 $1,476
Food & beverage: $1,466Education: $10
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $235 |
| E.R. Squibb & Sons, L.L.C. | 10 | $235 |
| ABBVIE INC. | 12 | $198 |
| Janssen Pharmaceuticals, Inc | 4 | $171 |
| Axsome Therapeutics, Inc. | 9 | $162 |
| Otsuka America Pharmaceutical, Inc. | 7 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $136 |
| Alkermes, Inc. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 2 | $31 |
Products named: COBENFY, VRAYLAR, AUSTEDO XR, Auvelity, CAPLYTA, INVEGA SUSTENNA, REXULTI, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
